Addressing the burden of hospital-related venous thromboembolism: the role of extended anticoagulant prophylaxis-Reference-Cited by-同舟云学术

Addressing the burden of hospital-related venous thromboembolism: the role of extended anticoagulant prophylaxis

Published:2018-02-26 Issue:3 Volume:16 Page:413-417
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Chan N. C.¹²,Gross P. L.¹²,Weitz J. I.¹²

Affiliation:

1. Thrombosis and Atherosclerosis Research Institute; McMaster University; Hamilton ON Canada

2. Department of Medicine; McMaster University; Hamilton ON Canada

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13942/fullpdf

Reference5 articles.

1. Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US;Heit;Blood,2017

2. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair;Forster;The Cochrane Database of Systematic Reviews,2016

3. Extended thromboprophylaxis with betrixaban in acutely Ill medical patients;Cohen;N Engl J Med,2016

4. Extended-duration betrixaban reduces the risk of stroke versus standard-dose enoxaparin among hospitalized medically ill patients: an APEX trial substudy (acute medically ill venous thromboembolism prevention with extended duration betrixaban);Gibson;Circulation,2016

5. The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications;Raskob;Thromb Haemost,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Clinical Decision Support with Mandatory versus Voluntary Venous Thromboembolism Risk Assessment in Hospitalized Patients;TH Open;2024-07

2. Venous Thromboembolism Prevention in Rehabilitation;American Journal of Physical Medicine & Rehabilitation;2024-06-21

3. Primary prevention of cancer-associated venous thrombosis: Rationale and challenges in clinical practice;Current Research in Translational Medicine;2023-07

4. Prévention et prise en charge des thromboses associées au cancer: questions pratiques à propos de l’anticoagulation;Bulletin du Cancer;2023-02

5. A review of venous thromboembolism risk assessment models for different patient populations: What we know and don’t!;Medicine;2023-01-13